Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Micro-dissected tumor tissues (MDTs) are maintained alive on chip for several days and show promising results for personalized medicine applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The MDTs were cultured and kept alive on the chip in a low-shear stress environment for extended time periods (over one week).”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [198]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [114]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [114]
In the citing paper
“Due to the direct use of tumor tissue, this approach includes many key components in tumor such as heterogeneous cell types and abnormal blood vessel networks.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [155]
In the citing paper
“In addition, the various types of cells in tumor tissues were all treated as tumor cells in these studies.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [155]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
Compilation of Henry's law constants (version 4.0) for water as solvent
Sander, R. (2015) · Atmospheric Chemistry and Physics · doi:10.5194/acp-15-4399-2015 · Cited by 2,873
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Rethinking ovarian cancer: recommendations for improving outcomes
Vaughan, S., Coward, J. I., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. C., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3144 · Cited by 1,464
Principles and Practice of Gynecologic Oncology
Moore, W. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199707000-00022 · Cited by 838
Research works printed but not linked: 4
- Vaupel, 1987, Cancer Res., 47, 3496
- Koch, 1978, Br. J. Cancer, Suppl., 3, 163
- H. Lamb , Hydrodynamics, Cambridge University Press, 6th ed., 1994
- Francis, 1933, J. Appl. Phys., 4, 403
Cited by
Microfluidic Organ-on-a-Chip Models of Human Intestine
Bein, A., Shin, W., Jalili-Firoozinezhad, S., Park, M. H., Sontheimer-Phelps, A., Tovaglieri, A., Chalkiadaki, A., Kim, H. J., & Ingber, D. E. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.12.010 · Cited by 625
Evolution of Biochip Technology: A Review from Lab-on-a-Chip to Organ-on-a-Chip
Azizipour, N., Avazpour, R., Rosenzweig, D. H., Sawan, M., & Ajji, A. (2020) · Micromachines · doi:10.3390/mi11060599 · Cited by 277
“These platforms with great potential to advance our understanding about tissue and organ physiology [11], offer portable and cost-effective biomedical tools for diseases modeling [12,13], pharmaceutical research [14,15] and personalized medicine [5,6].”
BackgroundMoshksayan, K., Kashaninejad, N., Warkiani, M. E., Lock, J. G., Moghadas, H., Firoozabadi, B., Saidi, M. S., & Nguyen, N.-T. (2018) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2018.01.223 · Cited by 267
Tumor-on-a-chip: from bioinspired design to biomedical application
Liu, X., Fang, J., Huang, S., Wu, X., Xie, X., Wang, J., Liu, F., Zhang, M., Peng, Z., & Hu, N. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00277-8 · Cited by 246
A microfluidics platform for combinatorial drug screening on cancer biopsies
Eduati, F., Utharala, R., Madhavan, D., Neumann, U. P., Longerich, T., Cramer, T., Saez-Rodriguez, J., & Merten, C. A. (2018) · Nature Communications · doi:10.1038/s41467-018-04919-w · Cited by 239
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Bitounis, D., Jacquinet, E., Rogers, M. A., & Amiji, M. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00859-3 · Cited by 224
“Microfluidics-based approaches can provide continuous oxygen and drug perfusion for sufficiently thin tissue sections 225 , but it is unclear whether continuous perfusion alone would suffice for the diffusion of LNP–mRNA throughout the organoid volume.”
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Trujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
“cultured microdissected tissues (MDTs), at dimensions below diameters of ~420 μm, on a simple microfluidic platform [198].”
BackgroundMehta, V., & Rath, S. N. (2021) · Bio-Design and Manufacturing · doi:10.1007/s42242-020-00112-5 · Cited by 163
Lee, J., Mehrotra, S., Zare‐Eelanjegh, E., Rodrigues, R. O., Akbarinejad, A., Ge, D., Amato, L., Kiaee, K., Fang, Y., Rosenkranz, A., et al. (2021) · Small · doi:10.1002/smll.202004258 · Cited by 143
Cancer-on-a-chip systems at the frontier of nanomedicine
Zhang, Y. S., Zhang, Y.-N., & Zhang, W. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.03.011 · Cited by 127
Applications of tumor chip technology
Hachey, S. J., & Hughes, C. C. W. (2018) · Lab on a Chip · doi:10.1039/c8lc00330k · Cited by 128
Gut-on-chip: Recreating human intestine in vitro
Xiang, Y., Wen, H., Yu, Y., Li, M., Fu, X., & Huang, S. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420965318 · Cited by 126
Bioengineering trends in female reproduction: a systematic review
Francés‐Herrero, E., Lopez, R., Hellström, M., de Miguel–Gómez, L., Herraiz, S., Brännström, M., Pellicer, A., & Cervelló, I. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac025 · Cited by 135
“Other drug screening models include microdissected tumor tissues in microfluidic culture (Astolfi et al., 2016) or alginate hydrogels (Salas et al., 2020), organoids of small cell neuroendocrine carcinoma of the uterine cervix (Tanaka et al., 2021) and ovarian cancer organoids, which have proven to…”
From 2D to 3D Cancer Cell Models—The Enigmas of Drug Delivery Research
Van Zundert, I., Fortuni, B., & Rocha, S. (2020) · Nanomaterials · doi:10.3390/nano10112236 · Cited by 107
“(A) A device containing a sinuous microchannel each of wh ch contains five microwells for s dimentation trapping of the loaded micr tissues or spheroids [127].”
MethodShim, S., Belanger, M. C., Harris, A. R., Munson, J. M., & Pompano, R. R. (2019) · Lab on a Chip · doi:10.1039/c8lc00957k · Cited by 108
A multiplexed microfluidic system for evaluation of dynamics of immune–tumor interactions
Moore, N., Doty, D., Zielstorff, M., Kariv, I., Moy, L. Y., Gimbel, A., Chevillet, J. R., Lowry, N., Santos, J., Mott, V., et al. (2018) · Lab on a Chip · doi:10.1039/c8lc00256h · Cited by 104
Barisam, M., Saidi, M. S., Kashaninejad, N., & Nguyen, N. (2018) · Micromachines · doi:10.3390/mi9030094 · Cited by 128
“[25] experimentally and numerically studied micro-dissected tumor (MDT) in a microfluidic device having some traps.”
BackgroundMethodInfluentialMultiplexed drug testing of tumor slices using a microfluidic platform
Horowitz, L. F., Rodriguez, A. D., Dereli-Korkut, Z., Lin, R., Castro, K., Mikheev, A. M., Monnat, R. J., Folch, A., & Rostomily, R. C. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0117-y · Cited by 88
Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD
Poletti, M., Arnauts, K., Ferrante, M., & Korcsmáros, T. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa257 · Cited by 110
Radhakrishnan, J., Varadaraj, S., Dash, S. K., Sharma, A., & Verma, R. S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.002 · Cited by 91
Microfluidics for studying metastatic patterns of lung cancer
Ruzycka, M., Cimpan, M. R., Rios-Mondragon, I., & Grudzinski, I. P. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0492-0 · Cited by 82
Rodenhizer, D., Dean, T., D'Arcangelo, E., & McGuigan, A. P. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701174 · Cited by 80
Organ-Tumor-on-a-Chip for Chemosensitivity Assay: A Critical Review
Kashaninejad, N., Nikmaneshi, M., Moghadas, H., Kiyoumarsi Oskouei, A., Rismanian, M., Barisam, M., Saidi, M., & Firoozabadi, B. (2016) · Micromachines · doi:10.3390/mi7080130 · Cited by 79
“With the emerging concept of lab-on-a-chip, in vitro microfluidic devices are closely linked to tissue engineering and regenerative science promising a great step toward personalized medicine [6].”
BackgroundA microfluidic platform for functional testing of cancer drugs on intact tumor slices
Rodriguez, A. D., Horowitz, L. F., Castro, K., Kenerson, H., Bhattacharjee, N., Gandhe, G., Raman, A., Monnat, R. J., Yeung, R., Rostomily, R. C., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc00811j · Cited by 77
Addressing Patient Specificity in the Engineering of Tumor Models
Bray, L. J., Hutmacher, D. W., & Bock, N. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00217 · Cited by 73
Multifunctional microfluidic chip for cancer diagnosis and treatment
Guo, Q., Zhang, L.-L., Liu, J., Li, Z., Li, J.-J., Zhou, W., Wang, H., Li, J., Liu, D., Yu, X., et al. (2020) · Nanotheranostics · doi:10.7150/ntno.49614 · Cited by 81
“Astolfi and colleagues described a method, named micro-dissected tissues (MDTs), in which patient derived tumor tissues were sectioned to submillimeter size [106].”
MethodResultInfluentialPowering ex vivo tissue models in microfluidic systems
McLean, I. C., Schwerdtfeger, L., Tobet, S. A., & Henry, C. S. (2018) · Lab on a Chip · doi:10.1039/c8lc00241j · Cited by 76
Experimental in vitro, ex vivo and in vivo models in prostate cancer research
Sailer, V., Amsberg, G. V., Duensing, S. M., Kirfel, J., Lieb, V., Metzger, E., Offermann, A., Pantel, K., Schüle, R., Taubert, H. W., et al. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00677-z · Cited by 82
Multi-size spheroid formation using microfluidic funnels
Marimuthu, M., Rousset, N., St‐Georges‐Robillard, A., Lateef, M. A., Ferland, M., Mes‐Masson, A., & Gervais, T. (2017) · Lab on a Chip · doi:10.1039/c7lc00970d · Cited by 71
Self-citationKumar, V., & Varghese, S. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801198 · Cited by 68
Spatially resolved microfluidic stimulation of lymphoid tissue ex vivo
Ross, A. E., Belanger, M. C., Woodroof, J. F., & Pompano, R. R. (2017) · The Analyst · doi:10.1039/c6an02042a · Cited by 63
Microdissected “cuboids” for microfluidic drug testing of intact tissues
Horowitz, L. F., Rodriguez, A. D., Au-Yeung, A., Bishop, K. W., Barner, L. A., Mishra, G., Raman, A., Delgado, P., Liu, J. T. C., Gujral, T. S., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc00801j · Cited by 62
A microfluidic cancer-on-chip platform predicts drug response using organotypic tumor slice culture
Chakrabarty, S., Quiros-Solano, W. F., Kuijten, M. M. P., Haspels, B., Mallya, S., Lo, C. S. Y., Othman, A., Silvestri, C., van de Stolpe, A., Gaio, N., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-0799 · Cited by 61
Shourabi, A. Y., Kashaninejad, N., & Saidi, M. S. (2021) · Journal of Science Advanced Materials and Devices · doi:10.1016/j.jsamd.2021.02.009 · Cited by 68
Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies
Bouquerel, C., Dubrova, A., Hofer, I., Phan, D. T. T., Bernheim, M., Ladaigue, S., Cavaniol, C., Maddalo, D., Cabel, L., Mechta-Grigoriou, F., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00531c · Cited by 58
Cellular Analysis Using Microfluidics
Sibbitts, J., Sellens, K. A., Jia, S., Klasner, S. A., & Culbertson, C. T. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04519 · Cited by 59
Nanomaterials assisted exosomes isolation and analysis towards liquid biopsy
Fang, X., Wang, Y., Wang, S., & Liu, B. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100371 · Cited by 65
Translational Aspects of 3D and 4D Printing and Bioprinting
Taylor, S., Mueller, E., Jones, L. R., Makela, A. V., & Ashammakhi, N. A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400463 · Cited by 68
Bourn, M. D., Batchelor, D. V. B., Ingram, N., McLaughlan, J. R., Coletta, P. L., Evans, S. D., & Peyman, S. A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.011 · Cited by 57
Kennedy, R., Kuvshinov, D., Sdrolia, A., Kuvshinova, E., Hilton, K., Crank, S., Beavis, A. W., Green, V., & Greenman, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-42745-2 · Cited by 59
The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
Fröhlich, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087116 · Cited by 57
Acute Lymph Node Slices Are a Functional Model System to Study Immunity Ex Vivo
Belanger, M. C., Ball, A. G., Catterton, M. A., Kinman, A. W. L., Anbaei, P., Groff, B. D., Melchor, S. J., Lukens, J. R., Ross, A. E., & Pompano, R. R. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00143 · Cited by 49
Brodeur, M. N., Simeone, K., Leclerc-Deslauniers, K., Fleury, H., Carmona, E., Provencher, D. M., & Mes‐Masson, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-97434-w · Cited by 54
Self-citationMimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs
van den Brand, D., Massuger, L. F., Brock, R., & Verdurmen, W. P. R. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00699 · Cited by 48
Bringing 3D tumor models to the clinic – predictive value for personalized medicine
Halfter, K., & Mayer, B. (2017) · Biotechnology Journal · doi:10.1002/biot.201600295 · Cited by 44
“Using interconnected channels, compounds or circulating tumor cells can be applied to the tumor samples and the biochemical composition of the resulting fluid may be assessed in regard to drug transport, targetreceptor binding, and overall cellular response [114].”
BackgroundCancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
Foglizzo, V., Cocco, E., & Marchiò, S. (2022) · Cancers · doi:10.3390/cancers14153692 · Cited by 51
“They showed that slices derived both from xenografted cell lines and patient-derived tumors can be maintained in culture for up to 8 days without perfusion and subjected to chemosensitivity assays [71].”
BackgroundMicrofluidics for personalized drug screening of cancer
Menon, N. V., Lim, S. B., & Lim, C. T. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.09.008 · Cited by 44
Microfluidics for interrogating live intact tissues
Horowitz, L. F., Rodriguez, A. D., Ray, T., & Folch, A. (2020) · Microsystems & Nanoengineering · doi:10.1038/s41378-020-0164-0 · Cited by 42
Rousset, N., Monet, F., & Gervais, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-00229-1 · Cited by 42
Self-citationHe, Y., Zhan, L., Shi, J., Xiao, M., Zuo, R., Wang, C., Liu, Z., Gong, W., Chen, L., Luo, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202207650 · Cited by 43
Maintenance of Head and Neck Tumor On-Chip: Gateway to Personalized Treatment?
Bower, R., Green, V. L., Kuvshinova, E., Kuvshinov, D., Karsai, L., Crank, S. T., Stafford, N. D., & Greenman, J. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0089 · Cited by 38
Mimicking and analyzing the tumor microenvironment
Crouigneau, R., Li, Y., Auxillos, J., Gonçalves‐Alves, E., Marie, R., Sandelin, A., & Pedersen, S. F. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100866 · Cited by 53
Cheah, R., Srivastava, R., Stafford, N. D., Beavis, A. W., Green, V., & Greenman, J. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4118 · Cited by 38
“This system mimics the nutrient exchange between capillaries and tissue in vivo . when the culture medium is perfused into the microchannel, the fluid layer near the channel is renewed rapidly while the liquid within the chamber mostly recirculates (31).”
BackgroundOn-chip clearing of arrays of 3-D cell cultures and micro-tissues
Grist, S. M., Nasseri, S. S., Poon, T. K. C., Roskelley, C. D., & Cheung, K. C. (2016) · Biomicrofluidics · doi:10.1063/1.4959031 · Cited by 35
Olubajo, F., Achawal, S., & Greenman, J. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.09.002 · Cited by 41
Dorrigiv, D., Simeone, K., Communal, L., Kendall‐Dupont, J., St‐Georges‐Robillard, A., Péant, B., Carmona, E., Mes‐Masson, A., & Gervais, T. (2021) · Cancers · doi:10.3390/cancers13164208 · Cited by 43
“Our group has introduced a microfluidics-based TECP, known as the micro-dissected tissue (MDT) [30,31], in which MDTs with sizes similar to large spheroids can be generated rapidly using conventional tissue slicing and punching methods.”
BackgroundMethodSelf-citationNew tools for immunologists: models of lymph node function from cells to tissues
Ozulumba, T., Montalbine, A. N., Ortiz-Cárdenas, J. E., & Pompano, R. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183286 · Cited by 37
Barisam, M., Saidi, M. H., Kashaninejad, N., Vadivelu, R. K., & Nguyen, N. (2017) · Micromachines · doi:10.3390/mi8120358 · Cited by 37
“To take into account the oxygen and glucose consumption rates by the cells, Equation (3c) was coupled with Michaelis–Menten reaction ([18,20,22,31,32]) term (Equation (4)):”
BackgroundMethodEngineering tissue‐specific blood vessels
Herron, L. A., Hansen, C. S., & Abaci, H. E. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10139 · Cited by 35
Dynamic Physiological Culture of Ex Vivo Human Tissue: A Systematic Review
Hughes, D. L., Hughes, A., Soonawalla, Z. F., Mukherjee, S., & O’Neill, E. (2021) · Cancers · doi:10.3390/cancers13122870 · Cited by 42
“(2016) [30] Ovarian and prostate tissue 20 μL/min Intermittent Micropipette pump 500 μL Active”
BackgroundInfluentialAn Interphase Microfluidic Culture System for the Study of Ex Vivo Intestinal Tissue
Baydoun, M., Treizeibré, A., Follet, J., Benamrouz-Vanneste, S., Creusy, C., Dercourt, L., Delaire, B., Mouray, A., Viscogliosi, É., Certad, G., et al. (2020) · Micromachines · doi:10.3390/mi11020150 · Cited by 33
“The extraction and interpretation of information also remains difficult as compared with simpler models of the organ [5].”
MethodAffolter, A., Lammert, A., Kern, J., Scherl, C., & Rotter, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.666515 · Cited by 36
Organ-on-Chip platforms to study tumor evolution and chemosensitivity
Dsouza, V. L., Kuthethur, R., Kabekkodu, S. P., & Chakrabarty, S. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188717 · Cited by 38
A microfluidic organotypic device for culture of mammalian intestinesex vivo
Richardson, A., Schwerdtfeger, L., Eaton, D., McLean, I. C., Henry, C. S., & Tobet, S. A. (2019) · Analytical Methods · doi:10.1039/c9ay02038a · Cited by 33
Pitingolo, G., Nizard, P., Riaud, A., & Taly, V. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.07.166 · Cited by 35
Uniformity of spheroids-on-a-chip by surface treatment of PDMS microfluidic platforms
Azizipour, N., Avazpour, R., Sawan, M., Rosenzweig, D. H., & Ajji, A. (2022) · Sensors & Diagnostics · doi:10.1039/d2sd00004k · Cited by 33
Testing Lab-on-a-Chip Technology for Culturing Human Melanoma Cells under Simulated Microgravity
Przystupski, D., Górska, A., Michel, O., Podwin, A., Śniadek, P., Łapczyński, R., Saczko, J., & Kulbacka, J. (2021) · Cancers · doi:10.3390/cancers13030402 · Cited by 29
“In the past decade, LOCs have found numerous biomedical applications, including integrated bioanalyses [1,2], metabolomics [3], drug discovery and delivery systems [4–7], cell analysis [8,9], tissue and organ physiology and disease modeling [10–12], and personalized medicine [11,13,14].”
BackgroundCook, S. R., Ball, A. G., Mohammad, A., & Pompano, R. R. (2024) · Lab on a Chip · doi:10.1039/d4lc00489b · Cited by 34
Abdulwahab, S., Ng, A. H. C., Chamberlain, M. D., Ahmado, H., Behan, L., Gomaa, H., Casper, R. F., & Wheeler, A. R. (2017) · Lab on a Chip · doi:10.1039/c7lc00170c · Cited by 29
Three-Dimensional Modeling of Avascular Tumor Growth in Both Static and Dynamic Culture Platforms
Taghibakhshi, A., Barisam, M., Saidi, M. S., Kashaninejad, N., & Nguyen, N. (2019) · Micromachines · doi:10.3390/mi10090580 · Cited by 32
“27 ×10−10 m2/s Diffusion coefficient of glucose through water [28]”
BackgroundInfluentialImaging Technologies for Microfluidic Biochips
Han, J., Kang, U., Moon, E., Yoo, H., & Gweon, B. (2022) · BioChip Journal · doi:10.1007/s13206-022-00067-y · Cited by 34
“6 Imaging tissue samples or animals within chips: A schematic of a multi-compartment tissue-on-a-chip for ex vivo drug testing [110], B schematic of a zebrafish-on-a-chip and two-photon images of zebrafish larval brain [116].”
BackgroundMethodSimeone, K., Guay-Lord, R., Lateef, M. A., Péant, B., Kendall‐Dupont, J., Orimoto, A. M., Carmona, E., Provencher, D. M., Saad, F., Gervais, T., et al. (2019) · Lab on a Chip · doi:10.1039/c8lc00982a · Cited by 33
Self-citationPlug-and-Play In Vitro Metastasis System toward Recapitulating the Metastatic Cascade
Ni, B.-S., Tzao, C., & Huang, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-54711-z · Cited by 27
Anti-Cancer Drug Screening with Microfluidic Technology
Monjezi, M., Rismanian, M., Jamaati, H., & Kashaninejad, N. (2021) · Applied Sciences · doi:10.3390/app11209418 · Cited by 30
“with benign prostatic hyperplasia) Carboplatin 1 [52] Preprints (www.”
BackgroundJackson, E., McDevitt, T. C., & Lu, H. (2017) · Lab on a Chip · doi:10.1039/c7lc00763a · Cited by 28
Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems
Patra, B., Lateef, M. A., Brodeur, M. N., Fleury, H., Carmona, E., Péant, B., Provencher, D. M., Mes‐Masson, A., & Gervais, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244549 · Cited by 31
Self-citationTestis-on-chip platform to study ex vivo primate spermatogenesis and endocrine dynamics
Sharma, S., Venzac, B., Burgers, T. C. Q., Schlatt, S., & Gac, S. L. (2022) · Organs-on-a-Chip · doi:10.1016/j.ooc.2022.100023 · Cited by 27
Novel biomarkers in cancer: The whole is greater than the sum of its parts
Samatov, T. R., Galatenko, V., Block, A., Shkurnikov, M. Y., Tonevitsky, A., & Schumacher, U. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.09.002 · Cited by 27
Personalized Drug Efficacy Monitoring Chip
Velasco, V., Joshi, K., Chen, J., & Esfandyarpour, R. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03291 · Cited by 26
Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screening
Zawawi, S. S. A., Salleh, E. A., & Musa, M. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00226 · Cited by 27
Microfluidic Platforms to Unravel Mysteries of Alzheimer’s Disease: How Far Have We Come?
Prasanna, P., Rathee, S., Rahul, V., Mandal, D., Goud, M. S. C., Yadav, P., Hawthorne, S. J., Sharma, A., Gupta, P. K., Ojha, S. K., et al. (2021) · Life · doi:10.3390/life11101022 · Cited by 28
Pre-activation of autophagy impacts response to olaparib in prostate cancer cells
Cahuzac, M., Langlois, P., Péant, B., Fleury, H., Mes‐Masson, A., & Saad, F. (2022) · Communications Biology · doi:10.1038/s42003-022-03210-5 · Cited by 31
Self-citationTechnological Advances in Tumor-On-Chip Technology: From Bench to Bedside
Bērziņa, S., Harrison, A., Taly, V., & Xiao, W. (2021) · Cancers · doi:10.3390/cancers13164192 · Cited by 29
Azizipour, N., Avazpour, R., Weber, M. H., Sawan, M., Ajji, A., & Rosenzweig, D. H. (2022) · Micromachines · doi:10.3390/mi13040587 · Cited by 27
“Spheroid formation on-chip has been achieved due to gravity by sedimentation and containment [43,44].”
BackgroundMicrofluidic technologies for ex vivo tissue biopsies: A review
Garcia-Garcia, F. C., Candarlioglu, P. L., Porter, J. D., Davies, D. E., Swindle, E. J., & Morgan, H. (2022) · Organs-on-a-Chip · doi:10.1016/j.ooc.2022.100020 · Cited by 23
Making In Vitro Tumor Models Whole Again
Wu, K. Z., Adine, C., Mitriashkin, A., Aw, B. J. J., Iyer, N. G., & Fong, E. L. S. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202279 · Cited by 25
Microphysiologic systems in female reproductive biology
Young, A. N., Moyle-Heyrman, G., Kim, J. J., & Burdette, J. E. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217697386 · Cited by 24
“Astolfi et al.(74) have developed a process for creating uniformly sized micro-dissected tissues (MDTs) from small clinical samples, such as biopsies, for use in a microfluidic device capable of extended culture and drug treatment.”
BackgroundContemporary Developments and Perspectives in International Health Security - Volume 1
Stawicki, S. P., Firstenberg, M. S., Galwankar, S. C., Izurieta, R., & Papadimos, T. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.84766 · Cited by 28
Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift
Lopez-Vince, E., Wilhelm, C., & Simón‐Yarza, T. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01580-3 · Cited by 26
“Their preclinical relevance and reliability have been assessed and confirmed [7, 8], laying the groundwork for potential scalability within the industry.”
BackgroundPillai, S., Kwan, J. C., Yaziji, F., Yu, H., & Tran, S. D. (2023) · Cancers · doi:10.3390/cancers15153894 · Cited by 25
Construction of cancer-on-a-chip for drug screening
Liu, Y., Yang, Q., Zhang, H., Han, S., Liu, N., Ren, H. J., Guo, H., & Xu, F. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.03.006 · Cited by 22
Microdissection tools to generate organoids for modeling the tumor immune microenvironment
Cordts, S. C., Yuki, K., Echeverri, M. F. H., Narasimhan, B., Kuo, C. J., & Tang, S. K. Y. (2024) · Microsystems & Nanoengineering · doi:10.1038/s41378-024-00756-8 · Cited by 22
“These results were surprising because, in previous work, organoids larger than ~200 – 500 µm were typically less viable, which was attributed to an inadequate nutrient supply and suboptimal oxygenation 28,38 – 41 .”
Fluorescence hyperspectral imaging for live monitoring of multiple spheroids in microfluidic chips
St‐Georges‐Robillard, A., Masse, M., Cahuzac, M., Strupler, M., Patra, B., Orimoto, A. M., Kendall‐Dupont, J., Péant, B., Mes‐Masson, A., Leblond, F., et al. (2018) · The Analyst · doi:10.1039/c8an00536b · Cited by 22
Self-citationUtharala, R., Grab, A. L., Vafaizadeh, V., Peschke, N., Ballinger, M., Türei, D., Tuechler, N., Ma, W., Ivanova, O., Ortiz, A. G., et al. (2022) · Nature Protocols · doi:10.1038/s41596-022-00740-4 · Cited by 23
Rapid Clearing for High Resolution 3D Imaging of Ex Vivo Pancreatic Cancer Spheroids
Steinberg, E., Orehov, N., Tischenko, K., Schwob, O., Zamir, G. A., Hubert, A., Manevitch, Z., & Benny, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207703 · Cited by 27
“There are many 3D techniques, each having a unique feature, such as: growing tissue specimens ex vivo [8], bioprinting cells in ECM [9], scaffold-based models [10], microfluidic devices [11], organoids [2], and multicellular tumor spheroids [12].”
BackgroundQuintard, C., Tubbs, E., Achard, J., Navarro, F. P., Gidrol, X., & Fouillet, Y. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.113967 · Cited by 33
3D stem-like spheroids-on-a-chip for personalized combinatorial drug testing in oral cancer
Mehta, V., Sudhakaran, S. V., Nellore, V., Madduri, S., & Rath, S. N. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02625-y · Cited by 23
“Intra-patient heterogeneity presents a critical challenge in functional drug testing based on micro-fluidic devices, as reported by the previous studies [55, 56].”
ResultA hitchhiker’s guide to cancer models
Budhwani, K. I., Patel, Z. H., Guenter, R. E., & Charania, A. A. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.04.003 · Cited by 22
Metadata
- Authors
- Astolfi, M., Péant, B., Lateef, M. A., Rousset, N., Kendall-Dupont, J., Carmona, E., Monet, F., Saad, F., Provencher, D., Mes-Masson, A.-M., & Gervais, T.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Polytechnique Montréal (CA)
- Institut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM)
- Corresponding author
- Gervais, T.
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2016
- Volume
- 16
- Issue
- 2
- Pages
- 312-325
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2185644008
- Cited by
- 182
- References
- 52
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 23 · 2023: 15 · 2022: 26 · 2021: 19 · 2020: 24 · 2019: 20 · 2018: 12 · 2017: 15 · 2016: 5
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- PolyPublie (École Polytechnique de Montréal) (submittedVersion)
- Funders
- Prostate Cancer Canada
- Canadian Cancer Society Research Institute
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- ex vivo drug testing, precision oncology, chemosensitivity testing, tissue viability, metabolite transport, xenograft mouse model, ovarian cancer, prostate cancer, benign prostatic hyperplasia, patient-derived tissue, tumor spheroids
- MeSH terms
- Animals, Antineoplastic Agents, Drug Evaluation, Preclinical, Flow Cytometry, Humans, Neoplasms, Microscopy, Confocal, Microdissection, Tissue Culture Techniques, Mice, Lab-On-A-Chip Devices, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.